Clinical Trial Details

< Previous Trial     Next Trial >
Study ID 200804050R
Investigator
We-Yu Hu,   National Taiwan University Hospital
Title The Effect on an Ionic Silver Dressing in Head and Neck Patients With Malignant Fungating Wound
Conditions Head and Neck Neoplasms
Head and Neck Cancer
Wounds
Ulcer
Interventions Other: silver-releasing dressings
Phase Phase 4
Purpose Background. Malignant fungating wounds(MFW) are caused by cancerous cells invading skin tissue, which exhibit increased bacterial burdens that not only result in a negative physical impact (odour, exudates, pain, and infection) on patients, impairing their quality of life, but they also increase treatment costs. A systematic review of the effectiveness of that the silver-releasing dressing in the management of infected chronic wounds can help enhance control of wound bed infection and inflammation, tissue management, moisture balance, and protect wound edge. However, few studies have examined the effects on people with MFW. Hypothses In this study that the hypothesized that cancer patients in the ionic silver dressing group will perception higher quality of life compared to patients in the control group who receive non-ionic silver dressing. In addition, we hypothesized that cancer patients who also receive ionic silver dressing will have lower level of symptom distress at end of study compared to patients in the control group receive non-ionic silver dressing care.
Eligibility Ages Eligible: 18 Years
Genders Eligible:  Both
Accepts Healthy Volunteers:  No
Inclusion Criteria:
  • (1.)Had a first time diagnosis of cancer of the breast or head and neck with MFW;
  • (2)Are at least more than 18 years of age or older, in order to focus the study on an adult population
  • (3)Present at malignant fungating wound more than one month old;
  • (4)Are able to speak and understand Chinese, in order to understand the consent form and the intervention and complete the study questionnaires
Exclusion Criteria:
  • (1) patients conscious unclear;
  • (2) Had seriously medical or psychology, such as hemodialysis;
  • (3) Had other comorbidity may interfere with intervention ion Criteria:
Study Location
Contact

Information objtained from ClinicalTrials.gov, on 7/23/2014. For additional information about this and other clinical trials, visit http://clinicaltrials.gov.
Please refer to this study by its ClinicalTrials.gov identifier: NCT00813631


Back to Search Results